|
Volumn 371, Issue 10, 2014, Pages 892-893
|
Sham controls in medical device trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BONE CEMENT;
PLACEBO;
ANALGESIA;
ARTERY PUNCTURE;
BLOOD PRESSURE;
CATHETERIZATION;
CLINICAL RESEARCH;
CORONARY ARTERY;
CRANIOTOMY;
DEVICE THERAPY;
EVIDENCE BASED PRACTICE;
FEMORAL ARTERY;
FETAL TISSUE TRANSPLANTATION;
FOOD AND DRUG ADMINISTRATION;
HEART DEATH;
HEART INFARCTION;
HUMAN;
IMPLANTATION;
INTERVENTION STUDY;
KIDNEY ANGIOGRAPHY;
KIDNEY DENERVATION;
MEDICAL DEVICE;
MEDICAL ETHICS;
MEDICARE;
MIGRAINE;
MORTALITY;
OUTCOME ASSESSMENT;
PARKINSON DISEASE;
PERCUTANEOUS CORONARY INTERVENTION;
PERCUTANEOUS VERTEBROPLASTY;
PROPHYLAXIS;
RADIOFREQUENCY ABLATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
RISK FACTOR;
SAFETY;
SHAM PROCEDURE;
THERAPY EFFECT;
ARTICLE;
DEVICE APPROVAL;
DEVICES;
DOUBLE BLIND PROCEDURE;
ETHICS;
HUMAN EXPERIMENT;
PLACEBO EFFECT;
RESEARCH ETHICS;
STANDARD;
DEVICE APPROVAL;
DOUBLE-BLIND METHOD;
EQUIPMENT AND SUPPLIES;
ETHICS, RESEARCH;
HUMANS;
PLACEBO EFFECT;
PLACEBOS;
THERAPEUTIC HUMAN EXPERIMENTATION;
|
EID: 84906996718
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1406388 Document Type: Article |
Times cited : (57)
|
References (5)
|